Catalyst Wire Dossier Catalyst Wire Dossier

Propagermanium

propagermanium · Dimerix Bioscience Pty Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Propagermanium, covering 2022-07-29 to 2022-07-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan [Phase 2]

See pricing